Carranza LS, Jiménez AM, Olhovich GI

Language: Spanish
References: 10
Page: 194-197
PDF size: 47.25 Kb.

ABSTRACT

Background: Ocular function is modified with hormone therapy; however, reports in literature are highly controversial.
Objective: To analyze how hormone therapy modifies intraocular pressure and the number of tears shed by Mexican women.
Patients and methods: Eighteen postmenopausal women were studied and randomly divided into two groups, according to the treatment they received: group 1, conjugated equine estrogens (CEE) 0.625 mg/day (n=9) (hysterectomized women with bilateral oophorectomy) and group 2, CEE 0.625 mg/day plus chlormadinone 1 mg/day (n=9) (women with intact uterus). Changes in intraocular pressure and Schirmer’s test were analyzed at baseline and three months after the treatment. Statistical analysis was performed with Student’s t test for independent and paired samples.
Results: There were no significant differences in intraocular pressure or Schirmer’s test among groups, neither when comparing baseline and final results in each group independently.
Conclusion: We could not demonstrate the effect of hormone replacement therapy on intraocular pressure and on Schirmer’s test after three months of its administration.

REFERENCES

1. Carranza LS. Atención integral del climaterio. 2a ed. México: Masson Doyma, 2002.

2. Carranza LS. Terapia hormonal de reemplazo. México: McGraw-Hill Interamericana, 2000.

3. Metka M. Ophthalmic complaints as a climacteric symptom. Maturitas 1991;14:3-8.

4. Sorrentino C. Effect of hormone replacement therapy on postmenopausal ocular function. Minerva Ginecol 1998;50:19-24.

5. Guaschino S, Grimaldi E, Sartore A, Mugittu R, Mangino F, Bortoli P, et al. Visual function in menopause: the role of hormone replacement therapy. Menopause 2003;10:53-7.

6. Benítez del Castillo JM. Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology 1997;104:970-3.

7. Sator MO. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 1998;29:93-5.

8. Qureshi IA, Huang YB, Xi XR, Wu XD. Hormonal changes associated with menstrual cycle have no definite influence on ocular pressure. Proc Natl Sci Counc Repub China (B) 1997;21:49-53.

9. Vaughan D. Examen. En: Vaughan D, editor. Oftalmología general. 6ª ed. México: El Manual Moderno, 1992;pp:14-33.

10. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA 2001;286:2114-9.